Accuryn Medical
logo

HAYWARD, Calif., February 8, 2024 (Newswire.com) - Accuryn Medical, a leading innovator in addressing hospital-acquired acute kidney injury (AKI), announces the successful completion of its comprehensive restructuring and a new Board of Directors.

Christopher Dewey, the incoming Chairman of Accuryn Medical, said, “We are pleased to announce approval and confirmation of our reorganization plan. This achievement will allow Accuryn Medical to have a clean balance sheet and ample funding that enables us to continue to serve our customers and nearly 70,000 patients we have treated to date while delivering on our business plan (some key initiatives highlighted below). I would like to personally thank our patients, customers, employees, suppliers, partners, investors, advisors, and others involved in this process for their support and continued confidence in Accuryn Medical.”

Key initiatives include:

Software Upgrades: Accuryn recently launched several upgrades to complement Accuryn’s proprietary Active Drain Line technology. Noteworthy is AKI Detect software which detects oliguric Acute Kidney Injury (AKI) in accordance with KDIGO guidelines and provides clinicians early notification of kidney distress compared to the standard of care, serum creatine.

Product Portfolio Expansion: Accuryn Medical has expanded its product portfolio with the introduction of 10 new foley catheter sizes to meet the growing demand to treat a wider range of patients; all designed to reduce the risks associated with CAUTI.

The New Board of Directors: The new Board will be led by Chris Dewey. Dr. Maurice Ferre, Joe Urban (Accuryn’s chief executive officer who successfully navigated Potrero through the restructuring) and an additional two members will be announced next week.

Accuryn Medical is committed to addressing Acute Kidney Injury (AKI) through real-time renal assessment with the Accuryn Monitoring System, which could enable early intervention of AKI to reduce preventable mortality and morbidity. Headquartered in Hayward, California. For more information, visit www.accuryn.com.

Profound Research - Leadership Announcement
Pictured: Lora Parahovnik - Chief Executive Officer; Marty Anderson - Chief Operations Officer; Christopher Church - Chief Commercial Officer

NASHVILLE, Tenn., February 8, 2024 (Newswire.com) - Profound Research, a leading clinical trial site network, today announced key leadership appointments aimed at driving innovation and continuing growth. These appointments include Lora Parahovnik, Ph.D., MBA, as Chief Executive Officer, along with the internal promotions of Marty Anderson to Chief Operations Officer and Christopher Church to Chief Commercial Officer.

Dr. Parahovnik brings extensive experience to her new role. She most recently served as CEO at Accel Research Sites Network where her teams set industry benchmarks for patient-centric clinical research within modern healthcare ecosystems. 

“I am honored to join an organization with a vision deeply rooted in improving patient lives, ensuring access to innovative treatments, and propelling scientific and medical progress,” said Parahovnik. “It is a privilege to lead a team whose mission aligns seamlessly with my own values and aspirations.” 

Marty Anderson, promoted to Chief Operations Officer, has been a pivotal figure in Profound's journey, spearheading operations since the company's inception. Her 30-year experience in the clinical trial industry and dedication to operational excellence position Profound for continued growth in both quality and market presence. 

Christopher Church, promoted to Chief Commercial Officer, brings a wealth of experience in building successful commercial teams and driving business development initiatives within the clinical trial industry. His strategic leadership has been focal in expanding Profound's therapeutic area expansion and driving revenue growth. 

Dr. Jonathan Feldstein, President and co-founder of Profound Research, expressed his enthusiasm for these appointments, saying, "We are thrilled to welcome Lora Parahovnik as our CEO and to announce the well-deserved promotions of Marty Anderson and Christopher Church. Their combined ability and leadership will be instrumental in driving Profound Research forward as an industry leader dedicated to medical innovation and patient access to those treatments.”  

About Profound Research

Profound Research is an integrated clinical research network comprising trial sites embedded into independent physician practices. With a mission to expand access to clinical research for community patients and offer more therapeutic options to community physicians, Profound Research operates across Southern California, the Detroit metropolitan area, and is expanding nationwide. The company boasts a team of experienced research professionals dedicated to providing high-quality clinical research support to physicians and their patients. 

For inquiries, please contact:

[email protected]

PremierRad Logo

MIAMI, February 8, 2024 (Newswire.com) - Premier Radiology Services, LLC (“Premier”) is pleased to announce the acquisition of Specialists in Diagnostic Imaging, LLC (d/b/a “NationalRad”), a leading provider of subspecialty teleradiology services. Financial terms of the transaction were not disclosed.

NationalRad, based in Deerfield Beach, Florida, has been a trusted name in the radiology industry since 1999. The company is a market leader in subspecialty teleradiology and provides services for outpatient imaging centers, orthopedic practices, university healthcare systems, and professional sports teams. The acquisition will allow Premier to advance its strategy of improving patient care, increasing subspecialty offerings to outpatient imaging clients, and delivering best-in-class customer service. 

“We’re excited to work with NationalRad to increase and diversify our respective service offerings, increase our clinical capacity, and improve patient care and outcomes. Our customers and their patients will certainly benefit from our partnership with NationalRad’s leading physicians and best-in-class operations team," said Drew Gaudet, CEO of Premier. 

NationalRad provides reliable and accurate subspecialty interpretations to outpatient imaging centers, orthopedic practices, and clinicians on a nationwide basis. With a robust network of highly skilled radiologists, NationalRad focuses on Musculoskeletal Imaging (MSK) and Neuroradiology MRI exams.

Gaudet added, "National Radiology Associates has developed an exceptional customer base of some of the most respected orthopedics practices and outpatient imaging centers in the United States. Supported by a world-class network of subspecialty radiologists, NationalRad has demonstrated a remarkable track record of targeted and intentional growth and improved outcomes.” 

Dr. Michael Zlatkin, President of NationalRad, expressed his excitement about the partnership, saying, "With this partnership, NationalRad is poised to grow while remaining focused on fulfilling our mission of delivering first-rate patient care and subspecialized teleradiology services. With Premier by our side, we will attract even more skilled radiologists as we continue to invest in our technology and our talented team.”

About NationalRad

Based in Deerfield Beach, Florida, NationalRad is one of the nation’s leading subspecialty diagnostic radiology practices providing outstanding diagnostic radiology and consulting services, as well as helping private practice and imaging center clients optimize and grow their own practices. For more information, visit https://nationalrad.com/.

About Premier Radiology Services

Based in Miami, Florida, Premier Radiology Services, LLC is a leading provider of teleradiology services offering 24/7 coverage across a range of modalities and sub-specialties. With a network of over 100 radiologists, Premier interprets approximately two million medical images annually for a wide range of customers, serving the needs of primary care providers, mobile imaging providers, occupational health centers, urgent care providers, and outpatient imaging centers. Premier earned The Joint Commission’s Gold Seal of Approval^® for Ambulatory Care Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal is a symbol of quality that reflects a health care organization’s commitment to providing safe and quality patient care. For more information, visit https://premierradiologyservices.com/.

Iodine Software
logo

AUSTIN, Texas, February 5, 2024 (Newswire.com) - Iodine Software, a leading healthcare enterprise AI software company, today announced the launch of AwareUM, its newest software solution that helps hospitals streamline their utilization management programs. This launch highlights Iodine's prowess in harnessing artificial intelligence to augment scarce clinical resources, streamlining workflows that were once considered resistant to automation due to the indispensable role of clinical, human judgment.

“The debut of AwareUM reaffirms Iodine’s position at the forefront of innovation, signaling the evolution of our business to empower the nation’s leading health systems in navigating the entire clinical revenue cycle,” said William Chan, co-founder and CEO of Iodine. “Building on Iodine’s trailblazing role in the CDI domain, AwareUM will transform utilization management, propelling hospitals towards heightened productivity and efficiency. As a combined suite of solutions, AwareCDI and AwareUM will bridge the gap in communication between CDI and UM teams, empowering them to master the mid-revenue cycle by capturing accurate and thorough documentation, driving efficient workflows, and strengthening revenue integrity.”

AwareUM is powered by Iodine’s AI engine CognitiveML, with nearly 10 years of experience driving accurate clinical predictions from a rich dataset of 1.5 billion medical concepts and millions of patient admissions. By intelligently analyzing all clinical data and documentation in the medical record, AwareUM prioritizes cases for review at the right time and provides transparency and reasoning behind predictions, which enables the capture of correct patient status, streamlines the review process and puts key data at the reviewers’ fingertips. Additionally, AwareUM provides a dedicated hub for all UM work and helps teams communicate effectively with payers to establish medical necessity. AwareUM enables clinicians to work at the top of their license, automating important processes and improving overall efficiency.

AwareUM is already deployed in many top U.S. health systems with proven results: “AwareUM has transformed our approach to utilization reviews and allowed our nurses to focus more on understanding the patient’s needs by reducing the amount of time required for administrative tasks. With AwareUM, pertinent documentation and patient information is easily obtained, which has cut our review time by half. In addition, the case prioritization capabilities have helped us identify high-opportunity cases that need to be reviewed first, which has improved our observation rates significantly,” said Sarah Horner, Director of Case Management at Baptist Hospitals of Southeast Texas.

With significant expertise across the clinical revenue cycle, in addition to AwareUM, Iodine’s AwareCDI solution has helped more than 900 hospitals capture more than $1.5 billion in earned revenue through more efficient clinical documentation improvement (CDI). Together, AwareUM and AwareCDI streamline revenue cycle management operations, improving reimbursement and enabling providers to focus on the delivery of high-quality, patient-centric care.

For more information, visit www.iodinesoftware.com/aware-um

About Iodine Software

Iodine is an enterprise AI company that builds transformative technologies to help healthcare organizations realize the full value of the care provided. Across the clinical revenue cycle, Iodine’s solutions automate complex clinical tasks, create efficiencies and maximize revenue. The company’s powerful, predictive AI/ML engine emulates the judgment of clinicians by interpreting raw clinical data to generate real-time, highly focused, predictive insights. Clinicians and hospital administrators can leverage these insights to dramatically augment the management of care delivery – facilitating critical decisions, scaling clinical workforces through automation, and improving the financial position of health systems. For more information, please visit iodinesoftware.com.

Clarity Clinic
Clarity Clinic Logo

CHICAGO, February 5, 2024 (Newswire.com) - Clarity Clinic, a leading provider of mental health services, proudly announces its recent accreditation from The Joint Commission. This esteemed Gold Seal of Approval® signifies Clarity Clinic's unwavering dedication to maintaining exceptional standards and ensuring the delivery of safe, high-quality patient care. 

The accreditation process, overseen by The Joint Commission, involves rigorous evaluation of healthcare organizations to ensure compliance with stringent performance standards. The Joint Commission's standards are crafted in collaboration with healthcare professionals, measurement experts, and patients. Informed by scientific literature and expert consensus, these standards aid healthcare organizations in measuring, assessing, and enhancing performance, further demonstrating Clarity Clinic’s commitment to continuous improvement and adherence to industry best practices. 

"We are excited to announce that Clarity Clinic has received accreditation from The Joint Commission," stated Dr. Stacy Lott, COO. "This recognition underscores our ongoing commitment to providing the highest level of care to our patients and reflects the hard work and dedication of our entire team." 

Receiving this Gold Seal of Approval® serves as a testament to Clarity Clinic's ongoing efforts to prioritize patient safety and quality of care. Patients can trust that they are receiving treatment from a healthcare organization that upholds the highest standards of excellence.  

Clarity Clinic remains steadfast in its mission to empower individuals and families on their journey toward improved mental health and well-being. With this accreditation, Clarity Clinic continues to be a trusted resource for those seeking compassionate and effective mental health services. 

About Clarity Clinic      

Clarity Clinic offers leading psychiatry and therapy services with locations throughout Chicagoland, Illinois, and Northwest Indiana. Clarity Clinic is redefining mental health care through a leading network of mental health providers, who thoughtfully guide the whole person on their journey to find clarity and mental wellness by offering a comprehensive range of mental health services, including therapy, medication management, and innovative treatment options. In-person and online psychiatry and therapy appointments can be scheduled online.